A study of Thippili Legiam in the management of Uthiravatha suronitham (Rheumatoid Arthritis)
Phase 3
Completed
- Conditions
- Health Condition 1: M057- Rheumatoid arthritis with rheumatoid factor without organ or systems involvement
- Registration Number
- CTRI/2023/02/049663
- Lead Sponsor
- ational Institute of Siddha
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 10
Inclusion Criteria
Adults with rheumatoid arthritis based on EULAR/ACR score > 6/10
Patients who are willing to attend OPD or willing for admission IPD
Patients who are willing to undergo Radiological investigation and other laboratory investigation
Patient who are willing to sign the informed consent stating that he/ she will consciously stick to the treatment during 48 days but can stop opt out of the trail of his /her own conscious discretion
Exclusion Criteria
Pregnancy and lactating mother
Uncontrolled Diabetes mellitus
k/c/o Any other arthritis
History of trauma
Extra articular involvement of Rheumatoid arthritis
Characteristic deformities of hands and feet in Rheumatoid arthritis
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Assessment will be done by Universal pain assessment scale and Modified Health Assessment QuestionnaireTimepoint: 1 month - SCREENING <br/ ><br>2 months- DATA COLLECTION <br/ ><br>1 month - DATA ANALYSIS AND OUTCOME <br/ ><br>
- Secondary Outcome Measures
Name Time Method Differences in laboratory investigations such as RA factor, ESR, CRP, ASO titer, Anti CCP will be assessedTimepoint: 1 Month - SCREENING <br/ ><br>2 Months - PATIENT ENROLLEMENT <br/ ><br>1 Month - OUTCOME ASSESSMENT